Chemotherapy may increase the risk of thromboembolism through at least acute damage to the vessel wall; delayed damage to vessel endothelial integrity; and through the reduction of regulatory proteins of coagulation processes, such as decreased levels of protein C and S, or decreased levels of antithrombin III (ATIII). The gene discussed is SERPINC1; the disease is Thromboembolism.